In vivo, in vitro, in silico: Why computer modelling is the next evolution of the healthcare sector
International Conference on In Silico Medicine on 4 September
With In Silico offering an understanding of complexity on a scale never before known in human history, the concept of the right treatment for the right patient at the right time no longer becomes an aspiration – it becomes standard practice.
The Avicenna Alliance is proud to announce that it will be supporting the organisation of a large-scale international conference in the European Parliament presenting the newest developments of In Silico medicine. The conference will have a global dimension bringing together speakers from e.g. the EU, the USA, and India.
The collective work of Avicenna members from around the world will be showcased. Speakers including EU policy makers and a representative from the FDA will also present key insights on their perspectives on computer modelling and simulation in healthcare.
Influential speakers from the regulatory side, industry and academia will present their knowledge on in silico medicine. Participants will be able to engage with keynote speakers, both during the conference and afterwards at the networking reception.
The programme for the conference includes discussions of the following areas:
- In Silico Medicine and the Avicenna Alliance
- V&V40 EU
- Computational Modelling and Simulation and medicinal products’ lifecycle
- EU Institution perspective on in silico medicine
In Silico Week
The first week of September is all about In Silico medicine. In addition to the event on the 4th, the VPH Institute will organise a three-day conference on research on In Silico medicine in Zaragoza, Spain from 5-8 September. Europe will thus be at the heart of discussions on Computational Modelling and Simulation in Healthcare this week.
The conference will take place on 4 September from 15.00-17.00 followed by a networking reception. The location is the European Parliament in Brussels, Belgium.